AB
Arbutus Biopharma
ABUS·NASDAQVancouver CAFounded 199960 employees
Micro CapbiotechPublicVirology
Platform: HBV LNP
Market Cap
$0.1B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (ABUS)
Loading ABUS stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Pemimavacamten | ABU-1236 | Phase 2/3 | 2 | SMN2 | GIST | ||
| ABU-7780 | ABU-7780 | Phase 2/3 | 1 | CD3 | CSUACC |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)